Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.01
-
Shares outstanding
-
27,407,170
-
Total 13F shares
-
10,304,191
-
Share change
-
+91,422
-
Total reported value
-
$90,796,295
-
Put/Call ratio
-
19%
-
Price per share
-
$8.81
-
Number of holders
-
79
-
Value change
-
-$664,518
-
Number of buys
-
40
-
Number of sells
-
41
Institutional Holders of ICAD, INC. - Common Stock, par value $0.01 (ICAD) as of Q3 2020
As of 30 Sep 2020,
ICAD, INC. - Common Stock, par value $0.01 (ICAD) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,304,191 shares.
The largest 10 holders included
BlackRock Inc., G2 Investment Partners Management LLC, VANGUARD GROUP INC, FEDERATED HERMES, INC., Parkman Healthcare Partners LLC, Portolan Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Fairpointe Capital LLC, Schonfeld Strategic Advisors LLC, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
79
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.